H Lundbeck A/S v Alphapharm Pty Ltd

In the Federal Court of Australia, the case of H Lundbeck A/S versus Alphapharm Pty Ltd involves a dispute related to patent law, specifically concerning the grant and validity of a pharmaceutical patent. H Lundbeck A/S, the patent holder, has brought the action against Alphapharm Pty Ltd, which has applied for a licence under the patent. The primary issue revolves around the terms and conditions under which Alphapharm can manufacture and sell the patented pharmaceutical product.

The court was required to address several legal issues, including the appropriate procedural steps for the licence applications, the timing for filing evidence, and the allocation of costs in this preliminary stage of the proceedings. Additionally, the court needed to decide whether to stay the proceedings or to make directions for the filing of evidence towards the determination of all issues.

The court ruled that it was more appropriate for the licence applicants to first file evidence in support of their applications, followed by any evidence H Lundbeck intended to rely on. The court permitted the same periods for the filing of evidence as applies to substantive oppositions, based on the submissions and the relative complexity of the matter. The court refused the licence applicants' request for a stay of the proceedings and also declined H Lundbeck’s request for a determination of “threshold” issues, opting instead to make directions for the filing of evidence towards the determination of all issues. Regarding costs, the court made no award under Schedule 8 Part 1 as it was relevant to the hearing of the present matter.